Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients-Reference-Cited by-同舟云学术

Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients

Published:2016-02 Issue: Volume:91 Page:1-9
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Di Domenico Fabio,Pupo Gilda,Giraldo Esther,Badìa Mari-Carmen,Monllor Paloma,Lloret Ana,Eugenia Schininà Maria,Giorgi Alessandra,Cini Chiara,Tramutola Antonella,Butterfield D. Allan,Viña José,Perluigi Marzia

Funder

fondi di Ateneo Sapienza

RETICEF

INCLIVA Intramural Grant

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference52 articles.

1. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer’s disease;Fagan;Sci. Transl. Med.,2014

2. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease;Blennow;Alzheimer’s Dement.: J. Alzheimer’s Assoc.,2015

3. Alzheimer’s Disease Neuroimaging, I. Phosphorylated tau-Abeta42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer’s disease in multiplex immunoassay panels of cerebrospinal fluid;Harari;Biol. Psychiatry,2014

4. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease;Sunderland;J. Am. Med. Assoc.,2003

5. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?;Clark;Arch. Neurol.,2003

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of nicotinamide mononucleotide on Alzheimer’s disease through activating autophagy and anti-oxidative stress;Biomedicine & Pharmacotherapy;2024-09

2. Design, Synthesis, and Invitro Pharmacological Evaluation of Novel Resveratrol Surrogate Molecules against Alzheimer's Disease;Chemistry & Biodiversity;2024-08-10

3. Early oxidative stress and DNA damage in Aβ-burdened hippocampal neurons in an Alzheimer’s-like transgenic rat model;Communications Biology;2024-07-14

4. Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers;Antioxidants;2024-05-31

5. A Case for the Neuroprotective Potential of African Phytochemicals in the Management of Alzheimer’s Disease;Topics in Neurocognition [Working Title];2024-03-07